EGM
SPRY icon

Engineers Gate Manager’s ARS Pharmaceuticals SPRY Stock Holding History

Engineers Gate Manager’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379K Buy
+47,256
New +$453K ﹤0.01% 1577
2025
Q2 		– Sell
-18,583
Closed -$234K – 2513
2025
Q1 		$234K Buy
18,583
+2,224
+14% +$26.8K ﹤0.01% 1827
2024
Q4 		$173K Buy
+16,359
New +$229K ﹤0.01% 1914

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Engineers Gate Manager's SPRY Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in ARS Pharmaceuticals (SPRY) in Q1 2026: 47,256 shares worth $379K. The stake represents ﹤0.01% of the portfolio and ranks #1577 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in SPRY as recently as Q1 2025.

Engineers Gate Manager first reported a position in SPRY in Q4 2024 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • Engineers Gate Manager held 47,256 shares of ARS Pharmaceuticals worth $379K as of Q1 2026.
  • ARS Pharmaceuticals was a new Engineers Gate Manager position in Q1 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1577 holding.
  • Engineers Gate Manager first reported a position in ARS Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.